Claude Beaudoin

Prof. Claude Beaudoin

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
LSLauriane Sèdes
Lauriane Sèdes
LTLaura Thirouard
Laura Thirouard
SMSalwan Maqdasy
Salwan Maqdasy
MGManon Garcia
Manon Garcia
FCFrançoise Caira
Françoise Caira
DVDavid H Volle
David H Volle
Cholesterol is essential for mammalian cell functions and integrity. It is an important structural component maintaining the permeability and fluidity of the cell membrane. The balance between synthesis and catabolism of cholesterol should be tightly regulated to ensure normal cellular processes. Male reproductive function has been demonstrated to be dependent on cholesterol homeostasis. Here we review data highlighting the impacts of cholesterol homeostasis on male fertility and the molecular mechanisms implicated through the signaling pathways of some nuclear receptors.

Verified
Journal Article
Open access
PDF file
MGManon Garcia
Manon Garcia
LTLaura Thirouard
Laura Thirouard
LSLauriane Sedès
Lauriane Sedès
MMMélusine Monrose
Mélusine Monrose
HHHélène Holota
Hélène Holota
CBClaude Beaudoin
Claude Beaudoin
Structural and functional studies have provided numerous insights over the past years on how members of the nuclear hormone receptor superfamily tightly regulate the expression of drug-metabolizing enzymes and transporters. Besides the role of the farnesoid X receptor (FXR) in the transcriptional control of bile acid transport and metabolism, this review provides an overview on how this metabolic sensor prevents the accumulation of toxic byproducts derived from endogenous metabolites, as well as of exogenous chemicals, in coordination with the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR). Decrypting this network should provide cues to better understand how these metabolic nuclear receptors participate in physiologic and pathologic processes with potential validation as therapeutic targets in human disabilities and cancers.

13 May 2021 in Gut
Verified
Journal Article
Closed access
PDF file
EMEmmanuelle Martinot
Emmanuelle Martinot
LTLaura Thirouard
Laura Thirouard
HHHélène Holota
Hélène Holota
MMMélusine Monrose
Mélusine Monrose
MGManon Garcia
Manon Garcia
DVDavid H Volle
David H Volle

13 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
LTLaura Thirouard
Laura Thirouard
HHHélène Holota
Hélène Holota
MMMélusine Monrose
Mélusine Monrose
MGManon Garcia
Manon Garcia
AHAngélique De Haze
Angélique De Haze
DVDavid H Volle
David H Volle
Spermatogenesis is a process within the testis that leads to the production of spermatozoa. It is based on a population of spermatogonial stem cells, which have the capacity to self-renew and to differentiate throughout life to ensure the functions of reproduction are maintained. Male fertility disorders are responsible for half of the cases of infertility in couples worldwide. It is well known that cancer treatments are associated with reversible or irreversible fertility disorders. Busulfan (Bu) is an alkylating agent that significantly inhibits spermatogenesis. The present study relied on a combination of in vivo and in vitro approaches as well as RNAseq analysis to characterize the effects of Bu, in which mouse testes were used as a model. An in silico analysis revealed that many of the Bu-modulated genes are potentially regulated by the SIN3 Transcription Regulator Family Member A (SIN3A) and E2F Transcription Factor (E2F) families of transcription factors. The results demonstrate that the deregulated genes function in processes related to the cell cycle, DNA repair, and cell death mechanisms, including the Tumor Protein 53 (TP53) pathway. This reinforces the role of the TP53 signaling pathway as a major player in Bu effects. In addition, Bu altered the patterns of mRNA accumulation for various genes in undifferentiated spermatogonia. This work provides significant insight into the kinetics and impacts of busulfan, which could pave the way for developing strategies to minimize the impact of chemodrugs and, thus, could lead to germ cell lineage regeneration following anticancer treatments.

10 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
ARAmandine Rambur
Amandine Rambur
MVMarine VIALAT
Marine VIALAT
CBClaude Beaudoin
Claude Beaudoin
CLCorinne Lours-Calet
Corinne Lours-Calet
Jean-Marc LOBACCAROJean-Marc LOBACCARO
Jean-Marc LOBACCARO
CJCyrille de Joussineau
Cyrille de Joussineau
Prostate cancer is the most common cancer in aging men. Despite recent progress, there are still few effective treatments to cure its aggressive and metastatic stages. A better understanding of the molecular mechanisms driving disease initiation and progression appears essential to support the development of more efficient therapies and improve patient care. To do so, multiple research models, such as cell culture and mouse models, have been developed over the years and have improved our comprehension of the biology of the disease. Recently, a new model has been added with the use of the Drosophila accessory gland. With a high level of conservation of major signaling pathways implicated in human disease, this functional equivalent of the prostate represents a powerful, inexpensive, and rapid in vivo model to study epithelial carcinogenesis. The purpose of this review is to quickly overview the existing prostate cancer models, including their strengths and limitations. In particular, we discuss how the Drosophila accessory gland can be integrated as a convenient complementary model by bringing new understanding in the mechanisms driving prostate epithelial tumorigenesis, from initiation to metastatic formation.

6 April 2016 in Cell Cycle
Verified
Journal Article
Open access
RBRafik Boudra
Rafik Boudra
RLRosyne Lagrafeuille
Rosyne Lagrafeuille
CLCorinne Lours-Calet
Corinne Lours-Calet
CJCyrille de Joussineau
Cyrille de Joussineau
GLGaëlle Loubeau-Legros
Gaëlle Loubeau-Legros
CBClaude Beaudoin
Claude Beaudoin
The mammalian target of rapamycin (mTOR) plays essential roles in the regulation of growth-related processes such as protein synthesis, cell sizing and metabolism in both normal and pathological growing conditions. These functions of mTOR are thought to be largely a consequence of its cytoplasmic activity in regulating translation rate, but accumulating data highlight supplementary role(s) for this serine/threonine kinase within the nucleus. Indeed, the nuclear activities of mTOR are currently associated with the control of protein biosynthetic capacity through its ability to regulate the expression of gene products involved in the control of ribosomal biogenesis and proliferation. Using primary murine embryo fibroblasts (MEFs), we observed that cells with overactive mTOR signaling displayed higher abundance for the growth-associated Npm1 protein, in what represents a novel mechanism of Npm1 gene regulation. We show that Npm1 gene expression is dependent on mTOR as demonstrated by treatment of wild-type and Pten inactivated MEFs cultured with rapamycin or by transient transfections of small interfering RNA directed against mTOR. In accordance, the mTOR kinase localizes to the Npm1 promoter gene in vivo and it enhances the activity of a human NPM1-luciferase reporter gene providing an opportunity for direct control. Interestingly, rapamycin did not dislodge mTOR from the Npm1 promoter but rather strongly destabilized the Npm1 transcript by increasing its turnover. Using a prostate-specific Pten-deleted mouse model of cancer, Npm1 mRNA levels were found up-regulated and sensitive to rapamycin. Finally, we also showed that Npm1 is required to promote mTOR-dependent cell proliferation. We therefore proposed a model whereby mTOR is closely involved in the transcriptional and posttranscriptional regulation of Npm1 gene expression with implications in development and diseases including cancer.